Purvalanol B treatment of P. falciparum strain W2 cultures produced a reported fold change of 2.1 for proteasome component C8. In synchronized blood stage cultures of P. falciparum, Purvalanol B treatment produced a reported fold change of 5.1 for thioredoxin reductase 2. [1]
Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.
Proteasome component C8 response in P. falciparum cultures
Cell-based study · P. falciparum strain W2 [1]
P. falciparum strain W2 cultures treated with Purvalanol B showed a reported fold change of 2.1 for proteasome component C8.
Literature-Reported Treatment Conditions
- Exposure duration
- At 24 hours post invasion
- Method
- applied to cultures
- Vehicle
- DMSO
- Reported limits
- Concentration removed by unit check.
Methods and source locations
Compound reported in the paper: Purvalanol B
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Methods > SYBR® Green I parasite growth assay (S9); Methods > Culturing parasites with Purvalanol B (S23, S25); Table 1 legend (S116); Table 1 (T1.h1, T1.r1)
Proteasome component C8: Proteasome component C8; comparator: DMSO vehicle only for 12 hours — Methods > Culturing parasites with Purvalanol B (S23); Table 1 (T1.h1, T1.r1)
Thioredoxin reductase 2 response in synchronized parasite cultures
Cell-based study · Synchronized blood stage cultures of P. falciparum [1]
Synchronized blood stage cultures of P. falciparum treated with Purvalanol B showed a reported fold change of 5.1 for thioredoxin reductase 2.
Literature-Reported Treatment Conditions
- Treatment concentration
- 3X the IC50 concentration
- Exposure duration
- at 24 hours post-invasion were treated with 3X the IC50 concentration of Purvalanol B and allowed to incubate for a further 12 hours
- Vehicle
- DMSO
- Reported limits
- Not stated in the sentences used: route.
Methods and source locations
Compound reported in the paper: Purvalanol B
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Methods > Culturing parasites with Purvalanol B (S23, S25); Results > Quantitative real-time RT-PCR (S93); Table 2 legend (S117); Table 2 (T2.h1, T2.r4)
Thioredoxin reductase 2: Thioredoxin reductase 2; comparator: DMSO vehicle only for 12 hours — Results > Quantitative real-time RT-PCR (S93); Table 2 (T2.h1, T2.r4)